Market Tracker

02/05 5:16pm ET

Anacor Pharmaceuticals Inc (NASDAQ:ANAC)

72.91
Delayed Data
As of Feb 05
 -5.72 / -7.27%
Today’s Change
35.80
Today|||52-Week Range
156.93
-35.46%
Year-to-Date

Today’s Trading

Previous close78.63
Today’s open78.11
Day’s range72.02 - 80.44
Volume760,508
Average volume (3 months)806,423
Market cap$3.2B
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-198.10%
Earnings growth (this year)+24.90%
Earnings growth (next 5 years)+62.80%
Revenue growth (last year)+20.07%
P/E ratioNM
Price/Sales65.86
Price/Book40.02

Competitors

 Today’s
change
Today’s
% change
CBPOChina Biologic Produ...-4.42-3.63%
NBIXNeurocrine Bioscienc...-1.08-2.91%
AKRXAkorn Inc-0.18-0.71%
HZNPHorizon Pharma PLC-0.65-3.65%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$20.7M
Annual profit (last year)-$87.1M
Net profit margin-421.28%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Paul L. Berns
Chief Financial Officer &
Executive Vice President
Graeme Bell
Corporate headquarters
Palo Alto, California

Forecasts